The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells

Lithium treatment and cancer incidence in bipolar disorder

(2016) Lina Martinsson et al.   BIPOLAR DISORDERS

Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study

(2016) Ru-Yu Huang et al.   BRITISH JOURNAL OF PSYCHIATRY

p53-dependent up-regulation ofCDKN1Aand down-regulation ofCCNE2in response to beryllium

(2016) P. Gorjala et al.   CELL PROLIFERATION

Lithium, a Therapy for AD: Current Evidence from Clinical Trials of Neurodegenerative Disorders

(2016) Orestes V. Forlenza et al.   Current Alzheimer Research

WDR26 is a new partner of Axin1 in the canonical Wnt signaling pathway

(2016) Toshiyasu Goto et al.   FEBS LETTERS

The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lackingβ-Catenin/TCF Regulated Transcription

(2016) Wael M. Abdel-Rahman et al.   Gastroenterology Research and Practice

Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases

(2015) Eleonore Beurel et al.   PHARMACOLOGY & THERAPEUTICS

Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease

(2015) Marielza Andrade Nunes et al.   PLoS One

Lithium potentiates GSK-3β activity by inhibiting phosphoinositide 3-kinase-mediated Akt phosphorylation

(2014) Nie Tian et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Beryllium is an inhibitor of cellular GSK-3β that is 1,000-fold more potent than lithium

(2014) Swapna R. Mudireddy et al.   BIOMETALS

Wnt signalling induces accumulation of phosphorylated  -catenin in two distinct cytosolic complexes

(2014) J. P. Gerlach et al.   Open Biology

Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments

(2013) Margaret K. King et al.   PHARMACOLOGY & THERAPEUTICS

Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of β-Catenin

(2013) Woo Sang Lee et al.   PLoS One

Wnt/β-Catenin Signaling Pathway Upregulates c-Myc Expression to Promote Cell Proliferation of P19 Teratocarcinoma Cells

(2012) Shuai Zhang et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex

(2012) Vivian S.W. Li et al.   CELL

MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling

(2012) Yong Hoon Cha et al.   CELL CYCLE

Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells

(2012) Leslie A. Kirby et al.   PLoS One

The  -Catenin Destruction Complex

(2012) J. L. Stamos et al.   Cold Spring Harbor Perspectives in Biology

Adenomatous Polyposis Coli (APC) Regulates Multiple Signaling Pathways by Enhancing Glycogen Synthase Kinase-3 (GSK-3) Activity

(2011) Alexander J. Valvezan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

AMP-activated protein kinase attenuates Wnt/β-catenin signaling in human osteoblastic Saos-2 cells

(2011) Tomozumi Takatani et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Lithium Suppresses Astrogliogenesis by Neural Stem and Progenitor Cells by Inhibiting STAT3 Pathway Independently of Glycogen Synthase Kinase 3 Beta

(2011) Zhenzhong Zhu et al.   PLoS One

Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types

(2010) Priyatham Gorjala et al.   BIOMETALS

Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death

(2010) Francesco Piazza et al.   BMC CANCER

When pathways collide: collaboration and connivance among signalling proteins in development

(2010) Helen McNeill et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Stabilisation of β-Catenin Downstream of T Cell Receptor Signalling

(2010) Matthew Lovatt et al.   PLoS One

Validating GSK3 as anin vivotarget of lithium action: Table 1

(2009) W. Timothy O'Brien et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

PR55α, a Regulatory Subunit of PP2A, Specifically Regulates PP2A-mediated β-Catenin Dephosphorylation

(2009) Wen Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Abnormalities in brain structure and behavior in GSK-3alpha mutant mice

(2009) Oksana Kaidanovich-Beilin et al.   Molecular Brain

APC Is Essential for Targeting Phosphorylated β-Catenin to the SCFβ-TrCP Ubiquitin Ligase

(2008) YunYun Su et al.   MOLECULAR CELL